Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
441.00    -6.80 (-1.52%)
Bid:
440.80
Ask:
441.20
Spread: 0.40 (0.091%)
Market Cap: £2.27b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Trading Update

14 Apr 2021 07:00

RNS Number : 3601V
QinetiQ Group plc
14 April 2021
 

News release

 

QinetiQ Group plc

Trading Update

14 April 2021 - QinetiQ Group plc ("QinetiQ" or "the Group") today issues a trading update covering its fourth quarter to 31 March 2021.

Strong operational performance - upgrading full year guidance

Through continued disciplined execution of our strategy the Group has delivered strong performance through the fourth quarter. As a consequence, today we announce that we expect our results for the full year to 31 March 2021 to be above our previous guidance and above market consensus expectations.

Full year order intake has been strong, and subject to audit, we expect to deliver high teens percentage revenue growth, high single digit percentage revenue growth on an organic basis. We expect the full year underlying operating profit margin percentage to be modestly ahead of that delivered in the first half, resulting in underlying operating profit for the full year of at least £147m. Operating cash flow has been good and we retain a strong balance sheet with net cash at 31 March 2021 of at least £150m.

Our strong performance is underpinned by overachievement across the EMEA Services portfolio offsetting the modest COVID-19 impacts seen earlier in the year in Global Products, affecting the United States and Target Systems. In addition, the three businesses sold in the last year have generated a non-trading gain which will be partly offset by a goodwill impairment in our German business due to a more challenging business environment.

We retain our medium to long-term guidance: we are targeting mid-single digit percentage compound annual organic revenue growth over the next 5 years, with strategic acquisitions further enhancing this growth. We are targeting operating profit margin of 12-13%, although in the short-term we continue to anticipate margins being c.100bps lower, driven by increased investment on our digital transformation programme and by the evolution of our business mix. Capital expenditure is expected to be in the region of £90m to £120m per annum for the next two years.

Steve Wadey, Group Chief Executive Officer said:

"I am extremely proud of how our people have continued to deliver critical defence and security capabilities for our customers around the world, despite significant challenges due to COVID-19. We continued to adapt our ways of working, increased the scale of our ambition and evolved our strategy to meet the changing needs of our customers. As a result, we are now upgrading our full year guidance, demonstrating the Group's continued strong momentum."

Preliminary results

QinetiQ will announce its preliminary results on 20 May 2021. We will be hosting a virtual results presentation, details of which will be available on our website shortly at: www.QinetiQ.com/investors.

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

Recording and transcript of our 4 March 2021 investor seminar: Renewed ambition to accelerate sustainable growth, which covered our growth strategy in the US, our digital T&E investment and our approach to ESG, can be found here: https://www.qinetiq.com/en/investors/investor-seminars/renewed-ambition-to-accelerate-sustainable-growth

Inside information

This announcement contains inside information and the person responsible for making this announcement is Jon Messent, Company Secretary.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Chris Barrie, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7968 727289

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOSNRARUSAAR
Date   Source Headline
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report
25th May 20237:00 amRNSResults for the year ended 31 March 2023
10th May 20234:55 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSFourth Quarter Trading Update
12th Apr 202311:35 amRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSQinetiQ announces £259 million renewal of MSCA
30th Mar 20237:00 amRNSQinetiQ Awarded $92.6M Contract
23rd Mar 20235:00 pmRNSDirectorate Change
20th Mar 202310:30 amRNSDirector Declaration
15th Mar 20232:40 pmRNSDirector Declaration
10th Mar 20232:56 pmRNSDirector/PDMR Shareholding
17th Feb 20239:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSGary Stewart appointed CEO for Australia Sector
10th Feb 20231:14 pmRNSDirector/PDMR Shareholding
6th Feb 20231:44 pmRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSThird Quarter Trading Update
16th Jan 20237:00 amRNS£80m contract win with UK MOD
10th Jan 20233:43 pmRNSDirector/PDMR Shareholding
5th Jan 20232:38 pmRNSDirector Declaration
12th Dec 20225:23 pmRNSDirectorate Change
12th Dec 20221:44 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSCompletion of the acquisition of Air Affairs
23rd Nov 202212:16 pmRNSCompletion of the acquisition of Avantus
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSSecond Quarter Trading Update
11th Oct 20223:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:06 amRNSAcquisition of Air Affairs & disposal of Space NV
12th Sep 20223:28 pmRNSDirector/PDMR Shareholding
26th Aug 202212:53 pmRNSDirector/PDMR Shareholding
10th Aug 20223:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.